HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Nellist Selected Research

Angiomyolipoma

12/2017Severe bleeding complications and multiple kidney transplants in a patient with tuberous sclerosis complex caused by a novel TSC2 missense variant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Nellist Research Topics

Disease

36Tuberous Sclerosis (Bourneville's Disease)
08/2023 - 09/2002
8Neoplasms (Cancer)
01/2021 - 09/2002
7Hamartoma
01/2020 - 06/2005
5Intellectual Disability (Idiocy)
01/2021 - 02/2008
5Seizures (Absence Seizure)
03/2017 - 11/2006
3Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 01/2013
3Epilepsy (Aura)
01/2021 - 01/2013
2Inborn Genetic Diseases (Disease, Hereditary)
12/2022 - 04/2011
2Brain Neoplasms (Brain Tumor)
01/2021 - 11/2017
2Infantile Spasms (West Syndrome)
03/2015 - 01/2013
1Neurodevelopmental Disorders
01/2023
1Starvation
01/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Glioma (Gliomas)
01/2021
1Ganglioglioma
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Disease Progression
12/2017
1Hemorrhage
12/2017
1Metrorrhagia (Spotting)
12/2017
1Angiomyolipoma
12/2017
1Autistic Disorder (Autism)
03/2017
1Hypoglycemia (Reactive Hypoglycemia)
03/2015
1Partial Epilepsies (Epilepsy, Partial)
02/2015
1Neoplasm Metastasis (Metastasis)
10/2014
1Uveal melanoma
10/2014
1Inflammation (Inflammations)
01/2013
1Neurocutaneous Syndromes (Phakomatoses)
10/2009
1Focal Cortical Dysplasia
10/2009

Drug/Important Bio-Agent (IBA)

33trans-sodium crocetinate (crocetin)IBA
08/2023 - 06/2005
9Mechanistic Target of Rapamycin Complex 1IBA
01/2021 - 01/2013
5Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2002
4Tuberous Sclerosis Complex 2 ProteinIBA
10/2016 - 09/2002
3DNA (Deoxyribonucleic Acid)IBA
08/2023 - 06/2005
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2016 - 09/2002
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
2Tuberous Sclerosis Complex 1 ProteinIBA
10/2009 - 10/2002
1N-(4-isothiocyanatophenethyl)spiperoneIBA
08/2023
1Amino AcidsFDA Link
01/2021
1Insulin (Novolin)FDA Link
01/2021
1LipidsIBA
01/2021
1TOR Serine-Threonine KinasesIBA
01/2021
1EverolimusFDA Link
01/2018
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2018
1MTOR InhibitorsIBA
01/2018
1temsirolimusFDA Link
01/2018
1Sunitinib (Sutent)FDA Link
01/2018
1Lysine (L-Lysine)FDA Link
11/2016
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2015
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2015
1Glucose (Dextrose)FDA LinkGeneric
03/2015
1Sirolimus (Rapamycin)FDA Link
10/2013
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2013
1Proto-Oncogene Proteins c-mycIBA
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1Receptor for Advanced Glycation End ProductsIBA
01/2013
1Codon (Codons)IBA
11/2006
1Ribosomal Protein S6IBA
10/2002

Therapy/Procedure

1Hysterectomy
12/2017
1Salpingo-oophorectomy
12/2017
1Kidney Transplantation
12/2017
1Ketogenic Diet
03/2015